Allogene discontinues investigational antibody following patient death

U.S. biotechnology company Allogene Therapeutics is fully discontinuing the use of its experimental antibody ALLO-647 following the death of a patient in its pi...

CTC Clinical Trial Consultants AB

SGS Fimko Ltd.

Spatial Biology Studies in Lung Tissue using Spectral Microscopy

Spectral imaging with the ZEISS LSM 980 laser scanning confocal enables more complex studies of cell-cell interactions and locations in immunology research.

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

Agreement in the EU on eight years of data exclusivity for new medicines

New pharmaceuticals will be covered by eight years of data exclusivity, according to the proposed new pharmaceutical legislation that EU countries have now agre...

The scientist behind Novo Nordisk's obesity success: “I never stopped believing in GLP-1”

It took several years of failures in GLP-1 before Lotte Bjerre Knudsen and her colleagues found the right path – but when they did, it was a true breakthrough. ...

ZEISS Metrology Expert Tips

New video series provides valuable expert knowledge.

Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.

New Insights into Microscopy

Watch the recording of our free webinar.

Hundratals AI-projekt leder Astra Zeneca mot ambitiösa målet

Astra Zeneca arbetar för att ligga i framkant inom AI, en bärande faktor för att bolaget ska nå sitt mål om att lansera 20 nya läkemedel till år 2030. ”Om man i...

Large study: The benefits and risks of obesity medications

Medications such as Ozempic can reduce the risk of a range of different diseases and health conditions but also increase the risk of others. This is according t...

Scientific Solutions

Novo Nordisk accepterar förhandlade Medicare-priser för fetmaläkemedel

Novo Nordisk har ingått ett prisavtal med USA gällande läkemedelsprogrammet Medicare. Det uppger bolaget i sin delårsrapport.

The investor: “The major common diseases are hot again”

She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...

Alzinova tar steg mot fas II-studie i USA

Biofarmabolaget Alzinova hoppas kunna inleda en fas II-studie med sin vaccinkandidat mot Alzheimers under andra halvåret 2025.

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

Reveal the Structures and Functions of Life

Super-resolution microscopes from ZEISS.

SupraCube - In life Science

Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...

Så används Nobelupptäckten i läkemedelsutveckling

Regulatoriska T-celler håller immunförsvaret i schack, en upptäckt som nu belönas med nobelpriset i fysiologi eller medicin 2025. Qiang Pan Hammarström berättar...

Microscope and measuring machine in one

ZEISS O-INSPECT duo covers two essential applications in quality assurance.

From Valneva to the CEO position at NorthX – “I saw it as a great opportunity”

A new cell therapy for leukaemia, a vaccine in tablet form against cholera, and a proprietary mRNA line with the potential capacity to supply the entire Nordic ...

He takes over the chairmanship of Karolinska Development

Ben Toogood is appointed as the new chairman of Karolinska Developments.

Tau-targeted Alzheimer's drug gets Fast Track designation in the USA

Biogen's Alzheimer's candidate BIIB080 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).